Clin2
NCT07604805Possibly a fitRecruiting

Chinese herbal medicine for severe lung blood pressure

Idiopathic Pulmonary Hypertension

Part of Lungs & breathing clinical trials.

This trial tests whether Qishen Yiqi Dropping Pills, a traditional Chinese herbal medicine, can safely improve symptoms and heart function in people with severe pulmonary hypertension (abnormally high blood pressure in the lungs). You would take this medicine alongside or instead of other treatments to see if it helps you walk farther and feel better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have been diagnosed with pulmonary arterial hypertension (high pressure in lung blood vessels), confirmed by a heart catheterization procedure showing specific pressure levels
  • You experience severe shortness of breath or chest discomfort limiting daily activities (WHO Class III or IV)
  • You can walk between 100 and 440 meters in 6 minutes and your walking ability is stable
  • Your heart function is adequate (left ventricular ejection fraction above 40%) with no severe valve problems
  • Your liver, kidney, and blood clotting function are normal or only mildly affected

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06377761Recruiting
Qishen granules for heart failure with preserved pumping function

This trial tests a Chinese herbal medicine called Qishen Granules for people with heart failure who still have a normal pumping ability (ejection fraction 50% or higher). It may help reduce symptoms and improve heart function.

Guangzhou, Guangdong
NCT07687186Recruiting· Phase 3
Qishen Yiqi pills for chronic heart failure

This trial tests whether Qishen Yiqi Dripping Pills, a Chinese herbal medicine, can help people with chronic heart failure caused by coronary heart disease. It is for adults who have been on stable heart failure treatment for at least two weeks.

Bozhou, Anhui
NCT07143448Recruiting· Phase 1/Phase 2
Study of HS235 for pulmonary arterial hypertension in adults

This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.

Tampa, Florida
NCT06699420Recruiting· Phase 4
Qishenyiqi pill for small vessel heart disease

This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.

Jinan, Shandong
NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality
NCT07473700Recruiting· Phase 2
Study of TX000045 for lung scarring and high blood pressure in the lungs

This trial tests a new medicine called TX000045 for people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug can help improve breathing and daily function.

Phoenix, Arizona

Hear when a new Idiopathic Pulmonary Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.